(Q38617975)

4 September 2017

title

Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence (English)

1 reference

4 September 2017

Ron C Hogg

1 reference

4 September 2017

publication date

27 October 2015

1 reference

Nicotine and Tobacco Research

4 September 2017

published in

1 reference

4 September 2017

1 reference

4 September 2017

1 reference

4 September 2017

page(s)

509-523

1 reference

Monoamine oxidases and tobacco smoking

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase and cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase and tobacco dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase inactivation: from pathophysiology to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase: from genes to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Dopamine is a monoamine oxidase B substrate in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Current place of monoamine oxidase inhibitors in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Personality traits related to monoamine oxidase activity in platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Smoking only explains part of the associations between platelet monoamine oxidase activity and personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Brain monoamine oxidase A inhibition in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C]befloxatone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Inhibition of monoamine oxidase B in the brains of smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Low monoamine oxidase B in peripheral organs in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Selegiline transdermal system (STS) as an aid for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Effects of selegiline (L-deprenyl) during smoking and short-term abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Tranylcypromine enhancement of nicotine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Platelet monoamine oxidase activity in subgroups of alcoholics and controls: results from the Collaborative Study on the Genetics of Alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Platelet monoamine oxidase in healthy 9- and 15-years old children: the effect of gender, smoking and puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Both low and high activities of platelet monoamine oxidase increase the probability of becoming a smoker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Comparison of tests used to distinguish smokers from nonsmokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Irreversible inhibition of monoamine oxidase by some components of cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Role of acetaldehyde in tobacco smoke addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Intravenous self-administration of acetaldehyde in the rat as a function of schedule, food deprivation and photoperiod

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Possible involvement of acetaldehyde, norepinephrine and their tetrahydroisoquinoline derivatives in the regulation of ethanol seld-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Intraventricular self-administration of acetaldehyde, but not ethanol, in naive laboratory rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Involvement of acetaldehyde in alcohol addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Occurrence and partition of the beta-carboline norharman in rat organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

The impact of smoking and drinking on plasma levels of norharman

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Harman induces preference for ethanol in rats: is the effect specific for ethanol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Exposure to beta-carbolines norharman and harman

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Monoamine oxidase inhibition for tobacco pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Placing transdermal selegiline for major depressive disorder into clinical context: number needed to treat, number needed to harm, and likelihood to be helped or harmed

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Tranylcypromine: new perspectives on an "old" drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

Nicotine self-administration in animals and humans: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Identifiers

DOI

10.1093/NTR/NTV245

1 reference

4 September 2017

1 reference